戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 chemical stimuli (signaling lipids, volatile anesthetics).
2 rols, but only when urethane was used as the anesthetic.
3 sirtuin deacetylase SIRT2 as a target of the anesthetic.
4 bit a different pattern of spin responses to anesthetic.
5 ration of paravertebral musculature with the anesthetic.
6 in, and myosin light chain as targets of the anesthetics.
7  are used clinically as analgesics and local anesthetics.
8 mmalian brain, are major targets for general anesthetics.
9 s had active pacemakers at the time of their anesthetics.
10 nctionally inhibited by isoflurane and other anesthetics.
11  are targeted by benzodiazepines and general anesthetics.
12 diverse experimental conditions and types of anesthetics.
13 esthetics is very similar to that of general anesthetics.
14  electronic structure of proteins by general anesthetics.
15 pressure, temperature, signaling lipids, and anesthetics.
16 e fifth transmembrane domain (S5) in sensing anesthetics.
17  animals resistant to systemically delivered anesthetics.
18 at potentiates the effect of delivered local anesthetics.
19 haracterized a chemically active alkylphenol anesthetic (2-((prop-2-yn-1-yloxy)methyl)-5-(3-(trifluor
20      An alternative hypothesis proposes that anesthetics act on one or more brainstem or diencephalic
21                While the exact mechanisms of anesthetic action are unknown, the Meyer-Overton correla
22                                              Anesthetic action is also related to an anesthetic's hyd
23                                Understanding anesthetic action may help reveal brain mechanisms under
24 thetics, but molecular mechanisms underlying anesthetic action remain debatable.
25 own as the unitary lipid-based hypothesis of anesthetic action, has been challenged by evidence for d
26 ork to study the structural basis of general anesthetic action.
27 Here we exploit the observation that pungent anesthetics activate mammalian but not Drosophila TRPA1.
28                                These noxious anesthetics activate transient receptor potential ankyri
29 ts in cortical neurons and to verify loss of anesthetic-activated TASK currents from TASK(-/-) mice.
30 mpeting influences on the VLPO, a sleep- and anesthetic-active structure, has yet to be evaluated in
31 inhaled volatile (isoflurane or sevoflurane) anesthetic agent (n = 67).
32 s of initiating brexanolone infusion without anesthetic agent reinstatement in the following 24 hours
33                   Propofol is a sedative and anesthetic agent that can both activate GABA(A) receptor
34 nificant correlation between the duration of anesthetic agent use and DeltaVBR was found (Spearman r
35                                     Volatile anesthetic agent use in the intensive care unit, aided b
36 ed mutation at an interaction site for local anesthetic agents (F1760A) partially attenuated the effe
37 ve considerable potential to be developed as anesthetic agents and as drugs to treat brain disorders
38 uch higher (toxic) concentrations of certain anesthetic agents did alter lipid bilayer properties.
39                         Furthermore, because anesthetic agents have the unique ability to reversibly
40                                 Many general anesthetic agents regulate voltage-gated Na(+) (NaV) cha
41                                              Anesthetic agents were required for a median of 13 (IQR,
42        All exposed children received inhaled anesthetic agents, and anesthesia duration ranged from 2
43 endent on a known interaction site for local anesthetic agents.
44 ian TRPA1 residues into dTRPA1 recapitulates anesthetic agonism.
45 general anesthetics, barbiturates, and local anesthetics all display the same effect on melting trans
46 eta3Met-227 in betaM1 established that these anesthetics also bind to a homologous site, most likely
47 el, such as the desorption rate constants of anesthetic and agonist, are directly related to model-in
48 ng on the responses of geriatric patients to anesthetic and analgesic drugs used during ambulatory su
49 ave been solved, exhibit modulation by local anesthetic and anti-epileptic agents, allowing molecular
50                   We used lidocaine, a local anesthetic and antiarrhythmic drug, to probe the role of
51 nylphenyl) barbituric acid (R-mTFD-MPAB), an anesthetic and GABAAR potentiator, has been shown to inh
52 iturate that is a potent and stereoselective anesthetic and GABAAR potentiator, has identified a seco
53 n hypothesis, or why the lipophilicity of an anesthetic and its potency are generally proportional.
54  that nitrous oxide, an inhalational general anesthetic and N-methyl-D-aspartate receptor antagonist,
55 cation with patients and theater staff, full anesthetic and operating facilities, replicated patient
56 lar surface preparation consisted of topical anesthetic and povidone-iodine 5% without the use of pre
57 terization in assessment of aortic stenosis, anesthetic and surgical techniques, as well as post-oper
58 randomized to receive a TAP block with local anesthetics and dexamethasone, PILA with dexamethasone,
59 get of allosteric modulators such as general anesthetics and ethanol and is a major locus for hyperek
60 xious and vasorelaxant properties of general anesthetics and may prove useful in understanding effect
61  a broad range of chemically diverse general anesthetics and related nonanesthetics on lipid bilayer
62                                         Some anesthetics and sedatives have been shown to cause neuro
63 s review, we outline the history of volatile anesthetics and their effect on kidney function, briefly
64 other relevant channels sensitive to general anesthetics and, as shown here, to barbiturates, at clin
65 der typically triggered by potent inhalation anesthetics and/or the depolarizing muscle relaxant succ
66 -azipropofol activates TRPA1 like the parent anesthetic, and identify two photolabeled residues (V954
67 en that isoflurane is a widely used volatile anesthetic, and is used for inhalational long-term sedat
68  a group of gases including anesthetics, non-anesthetics, and anesthetic/convulsants on tubulin dynam
69  sodium channels are inhibited by many local anesthetics, antiarrhythmics, and antiepileptic drugs.
70                                     Although anesthetics appear to activate microglia, the increased
71                                      General anesthetics are both neuroprotective and neurotoxic with
72                                 Inhalational anesthetics are bronchodilators with immunomodulatory ef
73                                      General anesthetics are known to cause depression of the freezin
74 imal fMRI and neurovascular studies, however anesthetics are known to profoundly affect neural and va
75 use of both mechanical vibration and topical anesthetic as effective in children regardless of age gr
76 he potential binding mode of noxious general anesthetics at TRPA1.
77 hotolabeling of beta3Met-227 in betaM1 by an anesthetic barbiturate, R-[(3)H]methyl-5-allyl-5-(m-trif
78                    We show here that general anesthetics, barbiturates, and local anesthetics all dis
79        Administration of a long-acting local anesthetic between the mesh and the peritoneum significa
80 ic ligand-gated ion channels, the details of anesthetic binding and channel modulation are still deba
81    Val-136 and adjacent residues may mediate anesthetic binding and stabilize an open state regulated
82 lations presented herein demonstrate a novel anesthetic binding site in GLIC that is accessed through
83 found for a delta subunit contribution to an anesthetic binding site.
84                                  To identify anesthetic binding sites in an extrasynaptic GABAAR, we
85 resent a computational study identifying two anesthetic binding sites in the transmembrane domain of
86 rtook an in-depth study of alkylphenol-based anesthetic binding to synaptic membranes.
87          WT SoCal5 and SoCal5 with the local anesthetics binding site mutated (F1760A) could be expre
88             We used mutagenesis to probe the anesthetic-binding cavity as observed in a TASK-3 homolo
89 genized the residue Val-136, which lines the anesthetic-binding cavity, its flanking residues (132 to
90 ed anesthetics through binding at a putative anesthetic-binding cavity.
91 uman Na(V)1.5 variant with a mutation in the anesthetic-binding site (F1759A-Na(V)1.5) and demonstrat
92 ic modulators by binding to the intersubunit anesthetic-binding sites in the GABAAR transmembrane dom
93 date or R-mTFD-MPAB also establish that each anesthetic binds to the homologous site at the beta3-bet
94 plastic microfluidic biochip with an on-chip anesthetic biosensor that was characterized for the rapi
95 posable microfluidic biochip with an on-chip anesthetic biosensor using MIPs exhibited excellent perf
96 dure, all 3 patients underwent a retrobulbar anesthetic block followed by magnetic resonance imaging
97 possible, nonopioid medications and regional anesthetic blockade are effective alternatives for analg
98    After mesh placement, a long-acting local anesthetic (bupivacaine hydrochloride, 0.50%) or placebo
99         Fentanyl is well characterized as an anesthetic, but the basic physiological effects of fenta
100 ion channels (pLGICs) are targets of general anesthetics, but molecular mechanisms underlying anesthe
101 es indicate that early postnatal exposure to anesthetics can lead to lasting deficits in learning and
102           Postconditioning with inhalational anesthetics can reduce ischemia-reperfusion brain injury
103                                  How general anesthetics cause loss of consciousness is unknown.
104   Exposure of young animals to commonly used anesthetics causes neurotoxicity including impaired neur
105 n the awake state, indicating that the novel anesthetic combination significantly minimizes the impac
106                                   Even supra-anesthetic concentrations caused minimal bilayer effects
107                                              Anesthetic concentrations in the membrane are high (10-1
108 ry (derived from mean end-tidal inhalational anesthetic concentrations).
109 ceptors under a wide range of agonist and/or anesthetic concentrations.
110                   This was provided using an Anesthetic Conserving Device and continued for 8 days.
111 were treated with volatile sedation using an anesthetic conserving device and isoflurane, and 322 rec
112  hypercapnia occurred more frequently during anesthetic conserving device use (6.4% vs 0%; p = 0.021)
113 ng of PaCO2 is necessary during sedation via anesthetic conserving device.
114  including anesthetics, non-anesthetics, and anesthetic/convulsants on tubulin dynamics.
115 ion provides corneal sensation in previously anesthetic corneas.
116                                     Volatile anesthetics did not attenuate glycocalyx shedding in hum
117                                 Inhalational anesthetic dose increase and reduced risk of postoperati
118                            High inhalational anesthetic dose of 1.20 (1.13-1.30) (median [interquarti
119                                 A single sub-anesthetic dose of ketamine exerts rapid and sustained a
120                                 A single sub-anesthetic dose of ketamine, a short-acting NMDA recepto
121    Converging evidence suggests a single sub-anesthetic dose of the N-methyl-D-aspartate receptor ant
122 ught to determine the effect of inhalational anesthetic dose on risk of severe postoperative respirat
123              Additionally, high inhalational anesthetic dose was associated with lower 30-day mortali
124    Intraoperative use of higher inhalational anesthetic doses is strongly associated with lower odds
125 e or one of three behaviorally relevant, sub-anesthetic doses of S-ketamine (5, 10, and 25 mg/kg, s.c
126 the deactivation of NsVBa, whereas the local anesthetic drug lidocaine was shown to antagonize NsVBa
127 ions (10-15 Hz) induced by the commonly used anesthetic drug propofol are synchronized between the th
128  support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis
129  results of preclinical studies suggest that anesthetic drugs administered to neonatal animals cause
130 This is a consequence of ideal mixing of the anesthetic drugs in the membrane fluid phase and exclusi
131 troencephalogram background suppression with anesthetic drugs) was tested.
132 alone were sufficient to markedly potentiate anesthetic duration when delivered centrally or peripher
133 an effective dose equivalent of inhalational anesthetics during surgery (derived from mean end-tidal
134                       Sedation with volatile anesthetics during therapeutic hypothermia may be a feas
135 transplant patients underwent 118 subsequent anesthetics during which they received neostigmine and g
136                    We identified the topical anesthetic dyclonine as protective.
137  an intravenous anesthetic that produces its anesthetic effect, largely via the GABAA receptor in the
138 lly relevant concentrations, indicating that anesthetic effects on ion channel function are not bilay
139  the modulation of agonist-induced traces by anesthetic, either coapplied or continuously present.
140 anesthetic state, thus priming the brain for anesthetic emergence.
141                    Patients undergoing local anesthetic endovenous thermal ablation were randomized t
142 loping safer general anesthetics, isomers of anesthetic ethers and barbiturates have been discovered
143 single in vivo treatment with the injectable anesthetic etomidate increased a tonic inhibitory curren
144 natures will be recapitulated by the general anesthetic etomidate, if the electrocortical effects of
145  a site overlapping with that of the general anesthetic etomidate.
146 ge, health status, and necessity of multiple anesthetic events.
147 ane, desflurane) and i.v. (propofol) general anesthetics excite peripheral sensory nerves to cause pa
148                                      General anesthetics exert their effects on the central nervous s
149 on studies support the conclusion that early anesthetic exposure may increase the risk of neurodevelo
150 ative lifelong risks and benefits of general anesthetic exposure should be considered when recommendi
151 which are thus vulnerable to perturbation by anesthetic exposure.
152 %) underwent a procedure while under general anesthetic for diagnostic purposes.
153  advantages of pharmacological sedatives and anesthetics for use in bronchoscopy.
154 ane site (TM2) that inhibits dissociation of anesthetic from the TM1 site and is consistent with the
155 rature supports the idea that common general anesthetics (GAs) cause long-term cognitive changes and
156 nts as a hypermetabolic response to volatile anesthetic gases, where susceptible persons may develop
157 ting, ventilation, and air conditioning, and anesthetic gases.
158 dine enhanced the efficacy of released local anesthetics, greatly increasing the number of triggerabl
159       At 3.0 T, the addition of steroids and anesthetics had minimal effect on signal intensity curve
160 is randomized study, we examined if volatile anesthetics have an effect on acute graft injury and cli
161                     We conclude that general anesthetics have minimal effects on bilayer properties a
162                                      General anesthetics have revolutionized medicine by facilitating
163                            Safety issues and anesthetic implications are also addressed.
164 ocols to regulatory the use of menthol as an anesthetic in aquaculture.
165           Bupivacaine is the indicated local anesthetic in caudal, epidural, and spinal anesthesia an
166 anisone/midazolam) and volatile (isoflurane) anesthetics in mice.
167                      Dosing studies of local anesthetics in peripheral nerve blockade suggest that ma
168                          The choice of local anesthetics in regional anesthesia depends on desired on
169      Despite the common use of sedatives and anesthetics in the acute phase of TBI management, their
170 ss of intersubunit binding sites for general anesthetics in the alpha1beta3gamma2 GABAAR transmembran
171 es of intersubunit-binding sites for general anesthetics in the GABAAR transmembrane domain.
172 ing the utilization and outcomes of regional anesthetics in this population.
173      The trend toward smaller doses of local anesthetics in ultrasound-guided regional anesthesia imp
174 inocular visual experience follows temporary anesthetic inactivation of the retinas.
175 ies suggest that modern halogenated volatile anesthetics induce potent anti-inflammatory, antinecroti
176 ental traces remarkably well, including both anesthetic-induced and agonist-induced traces, as well a
177            A recent hypothesis proposes that anesthetic-induced changes in ion channel function resul
178                       Molecular mechanism of anesthetic-induced depression of myocardial contraction.
179 in regions at natural sleep onset and during anesthetic-induced loss of righting reflex in rats.
180 tion, briefly review the studies on volatile anesthetic-induced renal protection, and summarize the b
181 rlying transitions between consciousness and anesthetic-induced unconsciousness remain unclear.
182 dation, and a single dose of ketamine during anesthetic induction and with dexmedetomidine compared w
183  = 167) or placebo (n = 168) initiated after anesthetic induction.
184           This treatment allowed the general anesthetic infusions to be weaned with resolution of sta
185  We recently observed that several n-alcohol anesthetics inhibit heterogeneity in plasma-membrane-der
186 uggest that halogenated inhalational general anesthetics interact with gates and pore regions of thes
187 dentification of the low millimolar volatile anesthetic interaction site of the calcium sensor protei
188 , has been challenged by evidence for direct anesthetic interactions with a range of proteins, includ
189                            Some evidence for anesthetic interactions with the cytoskeleton exists, bu
190 ral pressure that arise from partitioning of anesthetics into the bilayer.
191 tigate the efficacy of intraperitoneal local anesthetic (IPLA) on pain after acute laparoscopic appen
192             Generally the protein target for anesthetics is assumed to be neuronal membrane receptors
193                 A common endpoint of general anesthetics is behavioral unresponsiveness, which is com
194 pentameric ion channels by alkylphenol-based anesthetics is sufficient to induce modulation of activi
195    Thus, the thermodynamic behavior of local anesthetics is very similar to that of general anestheti
196                     Propofol, an intravenous anesthetic, is a positive modulator of the GABAA recepto
197 ic acid that finds an application as a local anesthetic, is found to adopt in its protonated form at
198 VLPO are directly depolarized by the general anesthetic isoflurane and hyperpolarized by norepinephri
199  concentration-response of TASK-3 to several anesthetics (isoflurane, desflurane, sevoflurane, haloth
200   In the process of developing safer general anesthetics, isomers of anesthetic ethers and barbiturat
201 tive to VAs yet resistant to the intravenous anesthetic ketamine [7].
202 es examining the effects of the dissociative anesthetic ketamine as a model for psychosis and as a ra
203                        Administration of sub-anesthetic ketamine immediately after the exposure preve
204                                        Among anesthetics, ketamine is remarkable in that it induces p
205 uency discharges of excitable cells by local anesthetics (LA) is largely determined by drug-induced p
206 als comparing epidural analgesia (with local anesthetics, lasting for >/= 24 hours postoperatively) w
207 identification is through the observation of anesthetic lesions on skin; however, up to 30% of infect
208  consciousness (LOC) and on through a deeper anesthetic level.
209                                 We find that anesthetic levels of pentobarbital reduce taste nerve re
210                           Although the local anesthetic lidocaine modulates inflammatory processes, t
211 one, and methylprednisolone) and three local anesthetics (lidocaine, ropivacaine, and bupivacaine) we
212                                              Anesthetic management and perioperative care were not st
213  to be aware of the unique challenges in the anesthetic management of the pediatric neurosurgical pat
214          The results therefore indicate that anesthetics may be potentially harmful not only in very
215                                      General anesthetics may control cell survival via their effects
216  the renal protective properties of volatile anesthetics may provide clinically useful therapeutic in
217                A better understanding of the anesthetic mechanism of action is necessary for the deve
218 ze the basic cellular mechanisms of volatile anesthetic-mediated protection against ischemic AKI.
219 hod was applied to residual determination of anesthetic menthol in fish.
220                Recent evidence suggests that anesthetics might cause persistent deficits in cognitive
221                                          The anesthetic mode-of-action for ketamine is mediated prima
222  widely attributed to suppressive actions of anesthetic molecules distributed by the systemic circula
223            Because of their roles as general anesthetics, n-alcohols are perhaps the best-studied amp
224 tly known modulators of GABA function (e.g., anesthetics, neurosteroids or ethanol).
225 ate the effect of a group of gases including anesthetics, non-anesthetics, and anesthetic/convulsants
226 nd the documentation of participation in the anesthetics of 20 trauma patients.
227 uires only that residents participate in the anesthetics of 20 trauma patients.
228 ngs were used to examine effects of volatile anesthetic on TASK currents in cortical neurons and to v
229                       The effects of general anesthetics on apoptosis and autophagy are closely integ
230 A kinetic model of the effect of agonist and anesthetics on ligand-gated ion channels, developed in e
231 hat hexadecanol acts oppositely to n-alcohol anesthetics on membrane mixing and antagonizes ethanol-i
232 implication for inhibitory action of general anesthetics on pLGICs.
233 may prove useful in understanding effects of anesthetics on related ion channels.
234 injection, and substitution ("tampering") of anesthetic opioids is unknown.
235 s were attributable to provider tampering of anesthetic opioids.
236 ding of analgesia devoid of the influence of anesthetics or restraints.
237 n these data that sedation with inhalational anesthetics outside of the operating room may likewise h
238                                The GABAergic anesthetics pentobarbital and propofol were also effecti
239 sity functional theory, we show that general anesthetics perturb and extend the highest occupied mole
240 ltrasound-guided foam sclerotherapy or local anesthetic phlebectomy.
241 hate and preperitoneal instillation of local anesthetic (PILA) with dexamethasone vs control on posto
242 -Overton correlation provides a link between anesthetic potency and solubility in a lipid-like, non-p
243 se results demonstrate that DeltaTc predicts anesthetic potency for n-alcohols better than hydrophobi
244  to further test the correlation between the anesthetic potency of n-alcohols and effects on Tc.
245 ns in a manner that is correlated with their anesthetic potency.
246 rodotoxin (TTX), which has ultrapotent local anesthetic properties.
247                                  Intravenous anesthetic propofol binds to 5-lipoxygenase and attenuat
248                                          The anesthetic propofol elicits many different spectral prop
249 chnology for the electrical detection of the anesthetic propofol in human plasma samples for clinical
250 r critical care therapy with the widely used anesthetic propofol on recovery from acute traumatic bra
251 ziPm) is a photoactive analog of the general anesthetic propofol.
252  during loss of consciousness induced by the anesthetic propofol.
253 activated and potentiated by the intravenous anesthetic propofol.
254 asal activity with the allosterically acting anesthetics propofol, pentobarbital, or alfaxalone.
255 e cortex, and postconditioning with volatile anesthetics provides neuroprotective actions that depend
256 ects of several clinically utilized volatile anesthetics, recent studies suggest that modern halogena
257                 Following fine-tuning of the anesthetic regime, stimulation elicited large and robust
258 s consistent with the high concentrations of anesthetics required to achieve clinical effects.
259                                              Anesthetic-resistant mutant strains of Drosophila exhibi
260                                   Whereas an anesthetic response is typically observed in the absence
261  values similar to those of the dissociative anesthetic (S)-(+)-ketamine.
262      Anesthetic action is also related to an anesthetic's hydrophobicity, permanent dipole, and polar
263 on method that permitted localization of the anesthetic-sensitive neurons with much improved spatial
264                  Interestingly, we show that anesthetics share with the antagonist A-967079 a potenti
265 th other substrates, which suggests that the anesthetic site is either created or stabilized in enzym
266 rophysiologic-based strategies for pediatric anesthetic state monitoring.
267 abilizes, but does not fully antagonize, the anesthetic state, thus priming the brain for anesthetic
268 ates arousal and may have effects on general anesthetic state.
269 e complete mechanistic underpinnings for the anesthetic state.
270                 These sites did not bind the anesthetic steroid alphaxalone, which enhanced photolabe
271 hysiology measurements suggest that volatile anesthetics such as isoflurane inhibit NaV by stabilizin
272    We demonstrated in the past that volatile anesthetics such as sevoflurane attenuate ischemia-reper
273 sults suggest that propofol and other common anesthetics, such as etomidate and ketamine, may target
274                                      General anesthetics suppress CNS activity by modulating the func
275 nical outcome measurement and a surrogate of anesthetic/surgical care quality.
276 sult in high plasma concentrations and local anesthetic systemic toxicity.
277 lecular motors have received no attention as anesthetic targets.
278 igns, and the ability to contact surgical or anesthetic teams outside of the theater via telephone.
279 roups (a TAP block and PILA) with a standard anesthetic technique with no regional technique (control
280                        Dexmedetomidine is an anesthetic that alters the level of arousal by selective
281                          Propofol, a general anesthetic that binds to GABAAR intersubunit sites, inhi
282 mal bupivacaine is a novel extended-duration anesthetic that has recently been used for local infiltr
283                   Propofol is an intravenous anesthetic that produces its anesthetic effect, largely
284 arbiturate, [(3)H]R-mTFD-MPAB, photoreactive anesthetics that bind with high selectivity to distinct
285 ion of brexanolone response during and after anesthetic third-line agent (TLA) weaning.
286 channel function is activated by halogenated anesthetics through binding at a putative anesthetic-bin
287 ropofol is the most widely used i.v. general anesthetic to induce and maintain anesthesia.
288  resulting from adsorption of agonist and/or anesthetic to the bilayer in which the protein is embedd
289      Finally, asymmetric binding patterns of anesthetic to the channel were found to promote an iris-
290              The addition of steroids and/or anesthetics to gadolinium solutions for MR arthrography
291                       Importantly, the early anesthetic treatment also reduced the subsequent escape
292             This effect was blocked by brief anesthetic treatment that prevented development of nocic
293 tinues or recurs despite 24 hours or more of anesthetic treatment.
294 f valve, imaging modalities, and the type of anesthetic used for the procedure.
295 nimize POCD in the choice and development of anesthetics used during surgeries for patients suffering
296             The mechanisms by which volatile anesthetics (VAs) produce their effects (loss of conscio
297 me the world's most popular volatile general anesthetic (VGA) before being abandoned because of its l
298  blood sample that was taken while a general anesthetic was administered.
299 errupted by propofol, an intravenous general anesthetic with putative actions on the inhibitory GABAA
300 ght (sitting), after instillation of topical anesthetic, with either the Icare PRO or the Tono-Pen fi

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top